ReviewMediastinum (Hong Kong, China)2025
Pathogenesis of thymoma-associated myasthenia gravis: a narrative review.
Review in Mediastinum (Hong Kong, China), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Thymoma Type B2 Associated with Myasthenia Gravis Presenting as Progressive Respiratory Distress: A Case Report.Cureus · 2026Article
- Case Report: Recurrent metastatic thymoma-associated multiple paraneoplastic syndromes: myasthenia gravis, dysgeusia, and acute intestinal pseudo-obstruction.Frontiers in oncology · 2026Article
- Evolving paradigms in thymoma surgery and multidisciplinary care: a narrative review.Mediastinum (Hong Kong, China) · 2026Review
- Hemodynamic response after preoperative embolization in thymoma-associated myasthenia gravis: associations with necrosis, HIF-1α expression, and CD163-positive macrophages.Frontiers in immunology · 2026Article
- Real-world study of efgartigimod in AChR antibody-positive generalized myasthenia gravis: thymus status, multi-domain symptom improvement and steroid-sparing effect.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Patients with thymomas often develop autoimmune neuromuscular diseases, including myasthenia gravis (MG). Autoantigen expression in thymomas plays an important role in disease pathogenesis. Since thymomas are mainly composed of the cortex, with few medullae, MG may be caused by immature thymoma-derived T cells that fail to undergo negative selection and have not yet acquired sufficient self-tolerance. However, due to the complexity and diversity of thymoma cell populations, a comprehensive understanding of the mechanisms underlying its association with MG has yet to be achieved. The purpose of this article is to provide an overview of the normal thymus function and the pathogenesis of thymoma associated with MG and other autoimmune diseases, with the aim to highlight newly identified mechanisms that may offer novel insights into their development. Methods: To address the lack of information regarding the MG-thymoma association, we applied a bioinformatics approach to thymomas. Key Content and Findings: By analyzing bulk RNA-sequencing (RNA-seq) and single-cell RNA-seq (scRNA-seq) data from thymomas, we identified neuromuscular medullary thymic epithelial cells (nmTECs) as neuromuscular antigen-expressing cell populations. Medullary structures, although much smaller than those of the normal thymus, are present in thymomas with MG and MG-susceptible genes are clustered. We observed spatial nmTEC colocalization and an immune niche, inferring an interaction and suggesting a pathological role of nmTECs in MG. Conclusions: After providing an up-to-date overview of normal thymus function, along with data and hypotheses regarding the association between thymoma and MG, we present bioinformatic findings regarding the thymoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.